Exo17v by Auricle Asia | Restore Your Skin Barrier

Exo17v

What is Exo17v?

Exo17v is an medical-grade exosome that an immune progenitor cells (Dynamic Linker Cell) that is derived through umbilical cord blood isolation.

Comprises of 3.3 billion particles of pure exosome, hyaluronic acid, polynucleotide, peptides and gluthathione, Exo17v aims to treat skin problems caused by chronic inflammation of the skin.

Types of Skin Problems

caused by chronic inflammation of the skin

Damage to progenitor cells

Reduces the ability of cells to repair DNA damage, which lead to acne scarring.

Epidermal barrier disruption infections

Tissue ischemia, hypoxia, which lead to acne sensitivity.

Reduced cell renewal rate

Acceleration in fibroblast aging, which is a precursor of ageing and sagging.

Destroys collagen, especially type 1

Hyaluronic acid and collagen loss resulting to dryness and dehydration of the skin.

Oxidative stress

Increased melanin production which lead to increase in pigmentation and spots.

Actual photo of HA-EXO17 taken by cryogenic electron tomography at the Korea Basic Science Research Institute.

Immune Exosome

The size and distribution of exosomes were confirmed using a nanoparticle tracking analyzer equipment which is the Marlven Nano sight 300, made by UK specified according to the extracellular vesicle guidelines of the Ministry of Food and Drug Safety(Korea FDA).

According to the analysis results, exosomes derived from DLC cells were distributed between 30 and 150 nm range, as defined in the definition of exosomes, and most nanoparticles were confirmed to be distributed within the 90 to 100 nm range.

The shape of exosomes derived from DLC cells was confirmed using Cryo-EM electron microscopy.

Based on the analysis results, the spherical shape and size of the DLC cell-derived exosomes were confirmed using cryogenic electron microscopy, and the double phospholipid structure of the DLC cell-derived exosomes was confirmed.

It was confirmed that the spherical shape and double phospholipid membrane structures were consistent.

Cell Migration Study

Migrate rapidly to heal and regenerate the damaged skin

Human Tissue Biopsy Study

Protocol

5 sessions recommended, at least 3 treatments recommended.

Every 2 weeks – 3 weeks (depending on patient recovery), after 5 sessions, maintenance is recommended every 6 months.

The effects of the treatment vary depending on the individual, but patient can expect to feel the change in skin texture 2-3 days after the treatment.

Intensive Treatment: Every 2 weeks (3 sessions)

Reinforcement Treatment: Every 1 month (2 sessions)

Maintenance Management: Every 6 months (1 session)